Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gjoerup OV"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hanna Tukachinsky, Jeffrey M. Venstrom, Jeffrey S. Ross, Geoffrey R. Oxnard, Russell Madison, Richard S.P. Huang, James Creeden, Douglas A. Mata, Virginia Fisher, Amado J. Zurita, Joaquin Mateo, Kira Raskina, Rachel Cunningham, Ryon Graf, Ole Gjoerup
Publikováno v:
Scientia
Background Biomarkers predicting second-generation novel hormonal therapy (NHT) benefit relative to taxanes are critical for optimized treatment decisions for metastatic castration-resistant prostate cancer (mCRPC) patients. These associations have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329691704b6f15dd686c7a0f97c2e376
https://hdl.handle.net/11351/9366
https://hdl.handle.net/11351/9366
Autor:
Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London ECMC, Barts Health, London, United Kingdom., Young A; Foundation Medicine, Cambridge, MA, United States., Nimeiri H; Foundation Medicine, Cambridge, MA, United States., Madison RW; Foundation Medicine, Cambridge, MA, United States., Fine A; Foundation Medicine, Cambridge, MA, United States., Zollinger DR; Foundation Medicine, Cambridge, MA, United States., Huang Y; Foundation Medicine, Cambridge, MA, United States., Xu C; Foundation Medicine, Cambridge, MA, United States., Gjoerup OV; Foundation Medicine, Cambridge, MA, United States., Aushev VN; Natera, Austin, TX, United States., Wu HT; Natera, Austin, TX, United States., Aleshin A; Natera, Austin, TX, United States., Carter C; Roche/Genentech, South San Francisco, CA, United States., Davarpanah N; Roche/Genentech, South San Francisco, CA, United States., Degaonkar V; Roche/Genentech, South San Francisco, CA, United States., Gupta P; Roche/Genentech, South San Francisco, CA, United States., Mariathasan S; Roche/Genentech, South San Francisco, CA, United States., Schleifman E; Roche/Genentech, South San Francisco, CA, United States., Assaf ZJ; Roche/Genentech, South San Francisco, CA, United States., Oxnard G; Foundation Medicine, Cambridge, MA, United States., Hegde PS; Foundation Medicine, Cambridge, MA, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Jul 31; Vol. 13, pp. 1221718. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).
Autor:
Graf RP; Foundation Medicine, Cambridge, MA., Fisher V; Foundation Medicine, Cambridge, MA., Huang RSP; Foundation Medicine, Cambridge, MA., Hamdani O; Foundation Medicine, Cambridge, MA., Gjoerup OV; Foundation Medicine, Cambridge, MA., Stanke J; Foundation Medicine, Cambridge, MA., Creeden J; Foundation Medicine, Cambridge, MA., Levy MA; Foundation Medicine, Cambridge, MA.; Rush University Medical Center, Chicago, IL., Oxnard GR; Foundation Medicine, Cambridge, MA., Gupta S; Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Aug; Vol. 6, pp. e2200121.
Autor:
Graf RP; Foundation Medicine, Cambridge, MA, USA. Electronic address: rgraf@foundationmedicine.com., Fisher V; Foundation Medicine, Cambridge, MA, USA., Mateo J; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain., Gjoerup OV; Foundation Medicine, Cambridge, MA, USA., Madison RW; Foundation Medicine, Cambridge, MA, USA., Raskina K; Foundation Medicine, Cambridge, MA, USA., Tukachinsky H; Foundation Medicine, Cambridge, MA, USA., Creeden J; Foundation Medicine, Cambridge, MA, USA., Cunningham R; Foundation Medicine, Cambridge, MA, USA., Huang RSP; Foundation Medicine, Cambridge, MA, USA., Mata DA; Foundation Medicine, Cambridge, MA, USA., Ross JS; Foundation Medicine, Cambridge, MA, USA., Oxnard GR; Foundation Medicine, Cambridge, MA, USA., Venstrom JM; Foundation Medicine, Cambridge, MA, USA., Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: azurita@mdanderson.org.
Publikováno v:
European urology [Eur Urol] 2022 Jan; Vol. 81 (1), pp. 37-47. Date of Electronic Publication: 2021 Oct 26.
Autor:
Tukachinsky H; Foundation Medicine Inc., Cambridge, Massachusetts., Madison RW; Foundation Medicine Inc., Cambridge, Massachusetts., Chung JH; Foundation Medicine Inc., Cambridge, Massachusetts., Gjoerup OV; Foundation Medicine Inc., Cambridge, Massachusetts., Severson EA; Foundation Medicine Inc., Cambridge, Massachusetts., Dennis L; Foundation Medicine Inc., Cambridge, Massachusetts., Fendler BJ; Foundation Medicine Inc., Cambridge, Massachusetts., Morley S; Foundation Medicine Inc., Cambridge, Massachusetts., Zhong L; Foundation Medicine Inc., Cambridge, Massachusetts., Graf RP; Foundation Medicine Inc., Cambridge, Massachusetts., Ross JS; Foundation Medicine Inc., Cambridge, Massachusetts.; Upstate Medical University, Syracuse, New York., Alexander BM; Foundation Medicine Inc., Cambridge, Massachusetts., Abida W; Memorial Sloan Kettering Cancer Center, New York, New York., Chowdhury S; Guy's, King's, and St. Thomas' Hospital, London, England, United Kingdom., Ryan CJ; University of Minnesota Medical School, Minneapolis, Minnesota., Fizazi K; Institut Gustave Roussy, Villejuif, France., Golsorkhi T; Clovis Oncology, Boulder, Colorado., Watkins SP; Clovis Oncology, Boulder, Colorado., Simmons A; Clovis Oncology, Boulder, Colorado., Loehr A; Clovis Oncology, Boulder, Colorado., Venstrom JM; Foundation Medicine Inc., Cambridge, Massachusetts., Oxnard GR; Foundation Medicine Inc., Cambridge, Massachusetts. goxnard@foundationmedicine.com.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3094-3105. Date of Electronic Publication: 2021 Feb 08.
Autor:
Forero A; Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213;, Giacobbi NS; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15213; and., McCormick KD; Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213;, Gjoerup OV; Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213;, Bakkenist CJ; Department of Radiation Oncology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213., Pipas JM; Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15213; and., Sarkar SN; Cancer Virology Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213; Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213; saumen@pitt.edu.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 Jun 15; Vol. 192 (12), pp. 5933-42. Date of Electronic Publication: 2014 May 05.
Autor:
Hu L; Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA., Filippakis H, Huang H, Yen TJ, Gjoerup OV
Publikováno v:
Journal of virology [J Virol] 2013 Dec; Vol. 87 (24), pp. 13179-92. Date of Electronic Publication: 2013 Sep 25.